Skip to main content

Advertisement

Log in

Raftlin and 8-iso-prostaglandin F2α levels and gene network analysis in patients with Modic changes

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Purpose

Oxidative stress in the vertebral endplates of patients with low back pain and Modic changes (MCs) (types I, II, and III) endplate changes on magnetic resonance imaging. 8-iso-prostaglandin F (8-iso-PGF) has been proposed as new indicator of oxidative stress. Raftlin, as an inflammatory biomarker, has been previously reported in inflammatory diseases. Oxidative stress plays an important role in various human diseases. This study was aimed to assess Raftlin and 8-iso-PGF levels in patients with MCs.

Methods

Patients with MCI, II, and III (n = 45) and age- and sex matched controls subjects (n = 45) were enrolled in this study. 8-iso-PGF and Raftlin levels in the serum samples of both groups were measured with enzyme-linked immunosorbent assay.

Results

In our study results, raftlin levels changed in parallel with prostaglandin levels (p < 0.05). Raftlin levels changed in parallel with prostaglandin levels (p < 0.05). The levels of 8-iso-PGF and Raftlin levels showed increase in patients with MCs and the control group (p < 0.05). In addition, a significant positive correlation was found between MC-I, MC-II, MC-III and Raftlin (r = 0.756, 0.733, 0.701 p < 0.001, respectively). A significant positive correlation was found between ISO (Respectively; r = 0.782, 0.712, 0.716 p < 0.001). In our evaluation between Raftlin and Iso, a significant positive relationship was determined. (r = 0.731, p < 0.001).

Conclusion

Our findings indicated that oxidative stress in patients with MC-I may be aggravated and it may cause an inflammation formation of the lesion areas in these patients. Also, the increased 8-iso-PGF and Raftlin levels in patients with MC-II and MC-III may be an adaptive response to against oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

All data available.

References

  1. Ay S, Evcik D (2008) Depression and quality of life in patients with chronic low back pain. New Med J 225:228–231

    Google Scholar 

  2. Guzman J, Esmail R, Karjalainen K, Malmivaara A, Irvin E (2001) Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ 322:1511–1516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Capkin E, Karkucak M, Cakırbay H, Topbas M, Karaca A, Köse MM, Gökmen F (2015) The prevalence and risk factors of low back pain in the eastern Black Sea region of Turkey. J Back Musculoskelet Rehabil 28(4):783–787

    Article  CAS  PubMed  Google Scholar 

  4. Kutsal YG (2000) Modern Medicine Seminars 11 Low Back Pain. Gunes Medical Bookstore, Ankara

    Google Scholar 

  5. Bianchi M, Peterson CK, Pfirrmann CWA, Hodler J, Bolton J (2015) Are the presence of MODIC changes on MRI scans related to improvement in low back pain patients treated with lumbar facet joint injections? BMC Musculoskelet Disord 16:234–258

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kuisma M, Karppinen J, Niinimäki J (2006) A three-year follow-up of lumbar spine endplate (modic) changes. Spine 31(15):1714–1718

    Article  PubMed  Google Scholar 

  7. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR (1988) Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 166(1):193–199

    Article  CAS  PubMed  Google Scholar 

  8. Braithwaite I, White J, Saifuddin A, Renton P, Taylor BA (1998) Vertebral end-plate (Modic) changes on lumbar spine MRI: correlation with pain reproduction at lumbar discography. Eur Spine J 7(5):363–368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. de Roos A, Kressel H, Spritzer C, Dalinka M (1987) MR imaging of marrow changes adjacent to end plates in degenerative lumbar disk disease. AJR Am J Roentgenol 149(3):531–534

    Article  PubMed  Google Scholar 

  10. Schmid G, Witteler A, Willburger R, Kuhnen C, Jergas M, Koester O (2004) Lumbar disk herniation: correlation of histologic findings with marrow signal intensity changes in vertebral endplates at MR imaging. Radiology 231(2):352–358

    Article  PubMed  Google Scholar 

  11. Girard CJ, Schweitzer ME, Morrison WB, Parellada JA, Carrino JA (2004) Thoracic spine disc-related abnormalities: longitudinal MR imaging assessment. Skeletal Radiol 33(4):216–222

    Article  PubMed  Google Scholar 

  12. Kjaer P, Leboeuf-Yde C, Korsholm L, Sorensen JS, Bendix T (2005) Magnetic resonance imaging and low back pain in adults: a diagnostic imaging study of 40-Year-old men and women. Spine 30:1173–1180

    Article  PubMed  Google Scholar 

  13. Peterson CK, Humphreys BK, Pringle TC (2007) Prevalence of modic degenerative marrow changes in the cervical spine. J Manipulative Physiol Ther 30(1):5–10

    Article  PubMed  Google Scholar 

  14. Lee W, Yoo H, Ku S, Kim S, Bae J (2014) Raftlin: a new biomarker in human sepsis. Inflammation 37:706–711

    Article  CAS  PubMed  Google Scholar 

  15. Avnioglu S, Güngör M, Kurutas E, Ozturk U, Demirhan I, Bakaris S, Velioglu H, Cankaya S, Yulug B (2022) The effect of resveratrol on sphingosine-1 and oxidative/ nitrosative stress in an experimental heart ischemia reperfusion model. Revista Romana de Medicina de Laborator 30(1):9–18. https://doi.org/10.2478/rrlm-2021-0036

    Article  Google Scholar 

  16. Morrow JD, Harris TM, Roberts LJ (1990) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 184:1–10

    Article  CAS  PubMed  Google Scholar 

  17. Pratico D, Rokach J, Lawson J, FitzGerald GA (2014) F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids 128:165–171

    Article  Google Scholar 

  18. Kaviarasan S, Muniandy S, Qvist R, Ikram SI (2004) F2-Isoprostanes as novel biomarkers for Type 2 diabetes: a review. J Clin Biochem Nutr 45:1–8

    Article  Google Scholar 

  19. Milne GL, Yin H, Morrow JD (2008) Human biochemistry of the isoprostane pathway. J Biol Chem 283:15533–15537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Low ESH, Krishnaswamy G, Thumboo J (2019) Comparing the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 systemic lupus international collaborating clinics (SLICC-12) criteria for systemic lupus erythematosus (SLE) classification: which enables earlier classification of SLE in an urban Asian population? Lupus 28(1):11–18. https://doi.org/10.1177/0961203318811599

    Article  CAS  PubMed  Google Scholar 

  21. Stein CM, Tanner SB, Award JA, Awad RJ, Morrow D (1996) Evidence of free-radical-mediated injury (isoprostane overproduction) in Scleroderma. Arthritis Rheum 39:1146–1150

    Article  CAS  PubMed  Google Scholar 

  22. Basu S, Whiteman M, Mattey DL, Halliwell B (2001) Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 60(6):627–631. https://doi.org/10.1136/ard.60.6.627.PMID:11350853;PMCID:PMC1753663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Albert HB, Manniche C (2007) Modic changes following lumbar disc herniation. Eur Spine J 16(7):977–982

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mok FP, Samartzis D, Karppinen J, Fong DY, Luk KD, Cheung KM (2016) Modic changes of the lumbar spine: prevalence, risk factors, and association with disc degeneration and low back pain in a large-scale population-based cohort. Spine J 16:32–41

    Article  PubMed  Google Scholar 

  25. Kurutas EB (2016) The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J 15(1):71. https://doi.org/10.1186/s12937-016-0186-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Grulovic B, Pucelj MR, Krnić M, Kokić V (2013) Impact of prostaglandin F2-alpha and tumor necrosis factor-alpha (TNF-alpha) on pain in patients undergoing thermal balloon endometrial ablation. Coll Antropol 37(4):1185–1190

    CAS  PubMed  Google Scholar 

  27. Helmersson J, Mattsson P, Basu S (2002) Prostaglandin F2α metabolite an F2-isoprostane excretion rates in migraine. Clin Sci 102:39–43

    Article  CAS  Google Scholar 

Download references

Funding

No funds were received in support of this work. No relevant financial activities outside the submitted work. Permission was obtained by the non-invasive clinical research ethics committee of Kahramanmaras Sutcu Imam University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to İlter Demirhan.

Ethics declarations

Conflict of interest

There is no conflict of interest among the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demirhan, İ., Oner, E., Yuksel, Z. et al. Raftlin and 8-iso-prostaglandin F2α levels and gene network analysis in patients with Modic changes. Eur Spine J 32, 2368–2376 (2023). https://doi.org/10.1007/s00586-023-07757-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-023-07757-7

Keywords

Navigation